Skip to main content
. Author manuscript; available in PMC: 2019 Jan 1.
Published in final edited form as: Alzheimer Dis Assoc Disord. 2018 Jan-Mar;32(1):35–42. doi: 10.1097/WAD.0000000000000220

Table 2.

Reaction to lack of reimbursement for amyloid imaging in the clinic (% represents positive responses unless otherwise noted)

PATIENTS AND CAREGIVERS:
% of
Patients
(n=87)
% of
Caregivers
(n=236)
P-value
POSITIVE (IN FAVOR OF AMYLOID IMAGING) 57.5 63.1 0.58
POSITIVE (EMOTIONALLY CHARGED) 33.3 25.8
NEUTRAL 8.0 8.9
NEGATIVE (NOT IN FAVOR OF AMYLOID IMAGING) 1.1 2.1
EARLY-ONSET AND LATE-ONSET:
% of Early-onset (n=215) % of Late-onset (n=270) P-value
POSITIVE (IN FAVOR OF AMYLOID IMAGING) 62.8 62.2 0.14
POSITIVE (EMOTIONALLY CHARGED) 28.4 23.0
NEUTRAL 7.0 13.0
NEGATIVE (NOT IN FAVOR OF AMYLOID IMAGING) 1.9 1.9
URBAN AND RURAL:
% of Urban (n=446) % of Rural (n=59) P-value
POSITIVE (IN FAVOR OF AMYLOID IMAGING) 63.5 64.4 0.41
POSITIVE (EMOTIONALLY CHARGED) 25.6 18.6
NEUTRAL 9.4 13.6
NEGATIVE (NOT IN FAVOR OF AMYLOID IMAGING) 1.6 3.4
U.S. REGIONS:
% of
Northeast
(n=83)
% of
Midwest
(n=114)
% of
South
(n=182)
% of
West
(n=119)
P-value
POSITIVE (IN FAVOR OF AMYLOID IMAGING) 63.9 66.7 63.2 63.0 0.95
POSITIVE (EMOTIONALLY CHARGED) 22.9 23.7 25.8 23.5
NEUTRAL 12.0 7.9 8.8 12.6
NEGATIVE (NOT IN FAVOR OF AMYLOID IMAGING) 1.2 1.8 2.2 0.8